Drug Profile
RP 527
Alternative Names: 99mTc-RP527; ReVele; RP527; Tc-99m-RP527; Technetium Tc 99m RP527; Technetium-99m RP527Latest Information Update: 20 Mar 2007
Price :
$50
*
At a glance
- Originator Bracco
- Class Oligopeptides; Radiopharmaceuticals; Technetium compounds
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 20 Mar 2007 Discontinued - Phase-II for Solid tumours diagnosis in Belgium (unspecified route)
- 08 Feb 2000 Phase-II clinical trials for Solid tumours diagnosis in Belgium (unspecified route)
- 24 Mar 1999 Phase-I clinical trials for Solid tumours diagnosis in Europe (unspecified route)